Global ELISpot and FluoroSpot Assay Market Growth (Status and Outlook) 2025-2031

Global ELISpot and FluoroSpot Assay Market Growth (Status and Outlook) 2025-2031

The global ELISpot and FluoroSpot Assay market size is predicted to grow from US$ 284 million in 2025 to US$ 635 million in 2031; it is expected to grow at a CAGR of 14.3% from 2025 to 2031.

The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.

Global eLISpot and fluoroSpot assay main players include CP Kelco, DowDuPont (Danisco), Cargill, Herbstreith & Fox, Andre Group, Silvateam, Naturex, Ceamsa, Anhui Jinfeng Pectin, Pomona’s Universal Pectin, Anhui Yuning, Bio-Technology, etc., totally accounting for about 80%. North America is the largest market, with s share over 45%. As for the types of products, it can be divided into assay kit and analyzer. The most common product is assay kit, holding a share over 62%. In terms of applications, it is widely used in diagnostic and research. The most application is research, with a share over 64%.

LPI (LP Information)' newest research report, the “ELISpot and FluoroSpot Assay Industry Forecast” looks at past sales and reviews total world ELISpot and FluoroSpot Assay sales in 2024, providing a comprehensive analysis by region and market sector of projected ELISpot and FluoroSpot Assay sales for 2025 through 2031. With ELISpot and FluoroSpot Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ELISpot and FluoroSpot Assay industry.

This Insight Report provides a comprehensive analysis of the global ELISpot and FluoroSpot Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ELISpot and FluoroSpot Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ELISpot and FluoroSpot Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ELISpot and FluoroSpot Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ELISpot and FluoroSpot Assay.

This report presents a comprehensive overview, market shares, and growth opportunities of ELISpot and FluoroSpot Assay market by product type, application, key players and key regions and countries.

Segmentation by Type:
Assay Kit
Analyzer
Others

Segmentation by Application:
Diagnostic
Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Oxford Immunotec
Cellular Technology Limited
BD
AID GmbH
Mabtech
Bio-Techne
Lophius Biosciences
Abcam
Biotech Investissement Group
U-CyTech biosciences.

Please note: The report will take approximately 2 business days to prepare and deliver.